The event will feature a presentation from Key Opinion Leader Thomas Heymann (President & CEO of Sepsis Alliance, USA), who will discuss the current treatment landscape and unmet medical need in treating patients with sepsis.

Sepsis patient advocate Mary Millard (International Speaker, Hospital Infections & Prevention) will speak about her journey, the unmet need, and the current standard of care in place. The Recce leadership team will discuss RECCE^® 327 intravenous formulation as a potential novel treatment solution.

A live question and answer session will follow.